Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user smiling while looking up at her son.
Potential OPDIVO® (nivolumab) user smiling while looking up at her son.

Clinical trial results for
advanced kidney
cancer, or renal cell
carcinoma (RCC)

See results for OPDIVO immunotherapy, alone or in combination with other therapies

Actor portrayals.

Advanced kidney cancer

OPDIVO + YERVOY

For certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Advanced kidney cancer

OPDIVO + CABOMETYX® (cabozantinib)

For certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Previously treated advanced kidney cancer

OPDIVO

For certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Hands exploring how OPDIVO® (nivolumab) works and learning how this treatment may help fight cancer.

How treatment works

See how this treatment may help your body fight cancer

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion



466-US-2400150   07/24